Although our findings did not show correlation with key clinicopathological features in invasive BC, mostly association with glutamine-metabolism-related genes, the findings may suggest that glutaminase isozymes expression in this subset of breast cancer is important in tumour biology rather than a clinical outcome in invasive BC. The gene discussed is GLS; the disease is breast cancer.